RenovoRx Net Income From Continuing Ops vs Income Tax Expense Analysis

RNXT Stock

USD 1.36 0.15 12.40%

RenovoRx financial indicator trend analysis is much more than just breaking down RenovoRx prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether RenovoRx is a good investment. Please check the relationship between RenovoRx Net Income From Continuing Ops and its Income Tax Expense accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RenovoRx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

For more information on how to buy RenovoRx Stock please use our How to Invest in RenovoRx guide.

Net Income From Continuing Ops vs Income Tax Expense

Net Income From Continuing Ops vs Income Tax Expense Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of RenovoRx Net Income From Continuing Ops account and Income Tax Expense. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between RenovoRx's Net Income From Continuing Ops and Income Tax Expense is -0.04. Overlapping area represents the amount of variation of Net Income From Continuing Ops that can explain the historical movement of Income Tax Expense in the same time period over historical financial statements of RenovoRx, assuming nothing else is changed. The correlation between historical values of RenovoRx's Net Income From Continuing Ops and Income Tax Expense is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income From Continuing Ops of RenovoRx are associated (or correlated) with its Income Tax Expense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Income Tax Expense has no effect on the direction of Net Income From Continuing Ops i.e., RenovoRx's Net Income From Continuing Ops and Income Tax Expense go up and down completely randomly.

Correlation Coefficient

-0.04

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Net Income From Continuing Ops

Income Tax Expense

Most indicators from RenovoRx's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into RenovoRx current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RenovoRx. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

For more information on how to buy RenovoRx Stock please use our How to Invest in RenovoRx guide.At this time, RenovoRx's Issuance Of Capital Stock is comparatively stable compared to the past year. Enterprise Value is likely to gain to about 44.5 M in 2024, whereas Selling General Administrative is likely to drop slightly above 3.5 M in 2024.

	2021	2023	2024 (projected)
Depreciation And Amortization	9K	5.4K	5.1K
Interest Income	57K	111K	64.4K

Depreciation And Amortization Interest Income

RenovoRx fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Common Stock	Current Deferred Revenue
Total Assets		-0.42	0.02	-0.08	0.88	0.62	-0.78	-0.15	0.07	1.0	-0.2	-0.02	-0.58	1.0	0.2	-0.03	-0.65	0.87	0.58	-0.67	0.88	1.0	0.2	0.98	0.2	0.2
Short Long Term Debt Total	-0.42		-0.8	-0.53	-0.66	-0.8	0.9	0.84	0.39	-0.41	-0.57	-0.72	0.85	-0.41	0.54	-0.69	0.83	-0.7	-0.84	0.73	-0.71	-0.42	0.54	-0.3	0.54	0.54
Other Current Liab	0.02	-0.8		0.92	0.13	0.28	-0.53	-0.51	-0.83	0.01	0.37	0.43	-0.38	0.01	-0.36	0.4	-0.34	0.22	0.36	-0.18	0.21	0.02	-0.36	-0.17	-0.36	-0.36
Total Current Liabilities	-0.08	-0.53	0.92		-0.15	-0.09	-0.27	-0.13	-0.98	-0.08	0.06	0.05	-0.01	-0.08	-0.07	0.05	0.01	-0.05	0.0	0.18	-0.06	-0.08	-0.07	-0.29	-0.07	-0.07
Total Stockholder Equity	0.88	-0.66	0.13	-0.15		0.91	-0.91	-0.58	0.22	0.87	0.21	0.45	-0.89	0.87	-0.2	0.4	-0.93	0.98	0.88	-0.94	1.0	0.88	-0.2	0.88	-0.2	-0.2
Net Tangible Assets	0.62	-0.8	0.28	-0.09	0.91		-0.88	-0.85	0.22	0.6	0.59	0.75	-0.99	0.6	-0.57	0.75	-0.98	0.88	0.97	-0.97	0.9	0.62	-0.57	0.62	-0.57	-0.57
Net Debt	-0.78	0.9	-0.53	-0.27	-0.91	-0.88		0.68	0.18	-0.76	-0.33	-0.53	0.9	-0.76	0.31	-0.5	0.92	-0.92	-0.89	0.86	-0.94	-0.78	0.31	-0.69	0.31	0.31
Retained Earnings	-0.15	0.84	-0.51	-0.13	-0.58	-0.85	0.68		-0.05	-0.13	-0.85	-0.96	0.89	-0.13	0.8	-0.95	0.83	-0.57	-0.88	0.79	-0.59	-0.15	0.8	-0.12	0.8	0.8
Accounts Payable	0.07	0.39	-0.83	-0.98	0.22	0.22	0.18	-0.05		0.07	0.1	0.12	-0.14	0.07	-0.06	0.13	-0.14	0.11	0.15	-0.3	0.13	0.07	-0.06	0.28	-0.06	-0.06
Cash	1.0	-0.41	0.01	-0.08	0.87	0.6	-0.76	-0.13	0.07		-0.22	-0.05	-0.55	1.0	0.21	-0.05	-0.64	0.86	0.56	-0.65	0.87	1.0	0.21	0.98	0.21	0.21
Non Current Assets Total	-0.2	-0.57	0.37	0.06	0.21	0.59	-0.33	-0.85	0.1	-0.22		0.82	-0.58	-0.22	-0.95	0.96	-0.48	0.18	0.56	-0.45	0.21	-0.2	-0.95	-0.2	-0.95	-0.95
Non Currrent Assets Other	-0.02	-0.72	0.43	0.05	0.45	0.75	-0.53	-0.96	0.12	-0.05	0.82		-0.8	-0.05	-0.79	0.91	-0.74	0.45	0.78	-0.71	0.45	-0.02	-0.79	-0.03	-0.79	-0.79
Other Assets	-0.58	0.85	-0.38	-0.01	-0.89	-0.99	0.9	0.89	-0.14	-0.55	-0.58	-0.8		-0.55	0.55	-0.75	0.99	-0.87	-0.99	0.97	-0.89	-0.58	0.55	-0.56	0.55	0.55
Cash And Short Term Investments	1.0	-0.41	0.01	-0.08	0.87	0.6	-0.76	-0.13	0.07	1.0	-0.22	-0.05	-0.55		0.21	-0.05	-0.64	0.86	0.56	-0.65	0.87	1.0	0.21	0.98	0.21	0.21
Common Stock Total Equity	0.2	0.54	-0.36	-0.07	-0.2	-0.57	0.31	0.8	-0.06	0.21	-0.95	-0.79	0.55	0.21		-0.88	0.44	-0.22	-0.48	0.41	-0.2	0.2	1.0	0.19	1.0	1.0
Common Stock Shares Outstanding	-0.03	-0.69	0.4	0.05	0.4	0.75	-0.5	-0.95	0.13	-0.05	0.96	0.91	-0.75	-0.05	-0.88		-0.67	0.36	0.75	-0.64	0.4	-0.03	-0.88	-0.03	-0.88	-0.88
Non Current Liabilities Total	-0.65	0.83	-0.34	0.01	-0.93	-0.98	0.92	0.83	-0.14	-0.64	-0.48	-0.74	0.99	-0.64	0.44	-0.67		-0.91	-0.99	0.99	-0.93	-0.66	0.44	-0.63	0.44	0.44
Other Current Assets	0.87	-0.7	0.22	-0.05	0.98	0.88	-0.92	-0.57	0.11	0.86	0.18	0.45	-0.87	0.86	-0.22	0.36	-0.91		0.85	-0.91	0.99	0.87	-0.22	0.85	-0.22	-0.22
Other Stockholder Equity	0.58	-0.84	0.36	0.0	0.88	0.97	-0.89	-0.88	0.15	0.56	0.56	0.78	-0.99	0.56	-0.48	0.75	-0.99	0.85		-0.97	0.88	0.58	-0.48	0.56	-0.48	-0.48
Total Liab	-0.67	0.73	-0.18	0.18	-0.94	-0.97	0.86	0.79	-0.3	-0.65	-0.45	-0.71	0.97	-0.65	0.41	-0.64	0.99	-0.91	-0.97		-0.93	-0.67	0.41	-0.68	0.41	0.41
Net Invested Capital	0.88	-0.71	0.21	-0.06	1.0	0.9	-0.94	-0.59	0.13	0.87	0.21	0.45	-0.89	0.87	-0.2	0.4	-0.93	0.99	0.88	-0.93		0.88	-0.2	0.86	-0.2	-0.2
Total Current Assets	1.0	-0.42	0.02	-0.08	0.88	0.62	-0.78	-0.15	0.07	1.0	-0.2	-0.02	-0.58	1.0	0.2	-0.03	-0.66	0.87	0.58	-0.67	0.88		0.2	0.98	0.2	0.2
Capital Stock	0.2	0.54	-0.36	-0.07	-0.2	-0.57	0.31	0.8	-0.06	0.21	-0.95	-0.79	0.55	0.21	1.0	-0.88	0.44	-0.22	-0.48	0.41	-0.2	0.2		0.19	1.0	1.0
Net Working Capital	0.98	-0.3	-0.17	-0.29	0.88	0.62	-0.69	-0.12	0.28	0.98	-0.2	-0.03	-0.56	0.98	0.19	-0.03	-0.63	0.85	0.56	-0.68	0.86	0.98	0.19		0.19	0.19
Common Stock	0.2	0.54	-0.36	-0.07	-0.2	-0.57	0.31	0.8	-0.06	0.21	-0.95	-0.79	0.55	0.21	1.0	-0.88	0.44	-0.22	-0.48	0.41	-0.2	0.2	1.0	0.19		1.0
Current Deferred Revenue	0.2	0.54	-0.36	-0.07	-0.2	-0.57	0.31	0.8	-0.06	0.21	-0.95	-0.79	0.55	0.21	1.0	-0.88	0.44	-0.22	-0.48	0.41	-0.2	0.2	1.0	0.19	1.0

Click cells to compare fundamentals

RenovoRx Account Relationship Matchups

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for RenovoRx Stock Analysis

When running RenovoRx's price analysis, check to measure RenovoRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RenovoRx is operating at the current time. Most of RenovoRx's value examination focuses on studying past and present price action to predict the probability of RenovoRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RenovoRx's price. Additionally, you may evaluate how the addition of RenovoRx to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

RenovoRx Net Income From Continuing Ops vs Income Tax Expense Analysis

Net Income From Continuing Ops vs Income Tax Expense

Net Income From Continuing Ops vs Income Tax Expense Correlation Analysis

Correlation Coefficient

Net Income From Continuing Ops

Income Tax Expense

RenovoRx fundamental ratios Correlations

RenovoRx Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for RenovoRx Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Stockholder Equity
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash

Other Stockholder Equity	- 0.99	Non Current Liabilities Total
Other Stockholder Equity	- 0.99	Other Assets
Other Assets	- 0.99	Net Tangible Assets
Non Current Liabilities Total	- 0.98	Net Tangible Assets
Accounts Payable	- 0.98	Total Current Liabilities
Total Liab	- 0.97	Other Stockholder Equity